DERM
DERM
NASDAQ · Pharmaceuticals

Journey Medical Corp

$5.17
-0.24 (-4.44%)
As of Nov 7, 2:15 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +202.9% upside
Low Target $10.95
Average Target $15.66
High Target $21.05
Current Price $5.17
Current
$5.17
Target
$15.66
$10.95 $15.66 avg $21.05
Scenario Analysis
Bear Case
$10.95
111.8%
Low target
Base Case
$15.66
+202.9%
Avg target
Bull Case
$21.05
+307.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$9.56
-45.9% from high
52-Week Low
$4.25
+21.6% from low
Target vs 52W High
$15.66
+63.9% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.01
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%